Literature DB >> 10358945

Effect of storage temperature on cell viability in cryopreserved canine aortic, pulmonic, mitral, and tricuspid valve homografts.

I Kashima1, R Yozu, H Shin, T Yamada, J Hata, S Kawada.   

Abstract

We determined how long cryopreserved aortic, pulmonic, mitral, and tricuspid valve homografts could be stored in a deep freezer (-80 degrees C) without compromising fibroblast viability. Valves harvested from 20 anesthetized mongrel dogs were grouped into nonfrozen control, frozen and stored in liquid nitrogen (-196 degrees C), and frozen and stored in a deep freezer (-80 degrees C). Frozen groups were divided into subgroups and stored for 2, 4, 8, or 12 weeks. A leaflet of each valve was divided into three fragments, and fibroblast viability was analyzed by flow cytometry. Cell viability was defined as staining by fluorescent diacetate but not by propidium iodide. The viability of untreated control valves from all four sites was about 70%, decreasing to about 50% when treated with low doses of antibiotics. The viability of frozen valves stored in liquid nitrogen was about 45% without a significant difference among storage periods. The viability of valves frozen and stored in a deep freezer was significantly lower than for the liquid nitrogen group at 2 weeks for the mitral valve and at 4 weeks for other valves. These results suggest that homografts can be stored in a deep freezer for up to 2 weeks without deterioration.

Entities:  

Mesh:

Year:  1999        PMID: 10358945     DOI: 10.1007/BF03217961

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  12 in total

1.  Effects of storage temperature on viable bioprosthetic heart valves.

Authors:  K G Brockbank; J F Carpenter; P E Dawson
Journal:  Cryobiology       Date:  1992-10       Impact factor: 2.487

2.  Cell-type-specific response to shock waves of suspended or pelleted cells as analysed by flow cytometry or electrical cell volume determination.

Authors:  E Endl; P Steinbach; J Schärfe; S Fickweiler; K Wörle; F Hofstädter
Journal:  Ultrasound Med Biol       Date:  1996       Impact factor: 2.998

3.  An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide.

Authors:  K H Jones; J A Senft
Journal:  J Histochem Cytochem       Date:  1985-01       Impact factor: 2.479

4.  Fibroblast viability in antibiotic treated valves.

Authors:  L Gonzalez-Lavin; N al-Janabi; E Lockey; D N Ross
Journal:  N Z Med J       Date:  1973-01

5.  A method of sterilizing and preserving fresh allograft heart valves.

Authors:  E Lockey; N Al-Janabi; L Gonzalez-Lavin; D N Ross
Journal:  Thorax       Date:  1972-07       Impact factor: 9.139

6.  Effects of storage temperature and fetal calf serum on the endothelium of porcine aortic valves.

Authors:  X J Feng; C E Van Hove; P J Walter; A G Herman
Journal:  J Thorac Cardiovasc Surg       Date:  1996-01       Impact factor: 5.209

7.  Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients.

Authors:  C Acar; M Tolan; A Berrebi; J Gaer; R Gouezo; T Marchix; J Gerota; S Chauvaud; J N Fabiani; A Deloche; A Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  1996-02       Impact factor: 5.209

8.  Donor heart valves: electron microscopic and morphometric assessment of cellular injury induced by warm ischemia.

Authors:  D G Crescenzo; S L Hilbert; M K Barrick; P C Corcoran; J D St Louis; R H Messier; V J Ferrans; R B Wallace; R A Hopkins
Journal:  J Thorac Cardiovasc Surg       Date:  1992-02       Impact factor: 5.209

9.  Allograft aortic valve replacement: long-term comparative clinical analysis of the viable cryopreserved and antibiotic 4 degrees C stored valves.

Authors:  M F O'Brien; D C McGiffin; E G Stafford; M A Gardner; P F Pohlner; G J McLachlan; K Gall; S Smith; E Murphy
Journal:  J Card Surg       Date:  1991-12       Impact factor: 1.620

10.  Six year review of the results of freehand aortic valve replacement using an antibiotic sterilized homograft valve.

Authors:  B G Barratt-Boyes; A H Roche; R M Whitlock
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.